SAN FRANCISCO Feb. 29 2012 PRNewswire Nektar Therapeutics Nasdaq NKTR today reported its financial results for the fourth quarter and year ended December 31 2011. Cash cash equivalents and investments at December 31 2011 were $414.9 million as compared to...
↧